BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9139332)

  • 1. [The anti-ischemic effects of ACE inhibitors after an acute myocardial infarct].
    Rutherford JD
    Rev Clin Esp; 1996 Dec; 196(4 Monografico):41-2. PubMed ID: 9139332
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-ischemic properties of ACE-inhibitors.
    Deedwania PC
    Cardiologia; 1996 Mar; 41(3):209-15. PubMed ID: 8697478
    [No Abstract]   [Full Text] [Related]  

  • 3. Angiotensin converting enzyme inhibitors--do they have an anti-ischemic action?
    Rutherford JD
    Trans Am Clin Climatol Assoc; 1996; 107():57-66; discussion 66-7. PubMed ID: 8725560
    [No Abstract]   [Full Text] [Related]  

  • 4. [Angiotensin-converting enzyme inhibition and angina pectoris].
    Odenthal HJ; Josephs W
    Dtsch Med Wochenschr; 1992 Nov; 117(48):1849-53. PubMed ID: 1451651
    [No Abstract]   [Full Text] [Related]  

  • 5. [The anti-ischemic effect of angiotensin-converting enzyme inhibitors in treating stable stenocardia of effort in middle-aged and elderly patients].
    Lazebnik LB; Vertkin AL; Drozdova SL; Konev IuV; Goncharov LF
    Ter Arkh; 1996; 68(4):40-2. PubMed ID: 9324787
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anti-ischemic and infarction-reducing effects of angiotensin-converting enzyme inhibitors].
    Landmark K; Aursnes I
    Tidsskr Nor Laegeforen; 2001 Jun; 121(16):1923-6. PubMed ID: 11488184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Suppression of angiotensin-converting enzyme and myocardial ischemia].
    Eliseev OM
    Ter Arkh; 1999; 71(3):73-6. PubMed ID: 10234773
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-ischaemic effects of ACE inhibitors: review of current clinical evidence and ongoing clinical trials.
    Yusuf S; Lonn E
    Eur Heart J; 1998 Sep; 19 Suppl J():J36-44. PubMed ID: 9796839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pragmatic approach to the use of angiotensin-converting enzyme inhibitors in acute myocardial infarction.
    Vantrimpont P; Rouleau JL
    Can J Cardiol; 1996 Oct; 12(10):924-9. PubMed ID: 9191482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    McMurray J; Solomon S; Pieper K; Reed S; Rouleau J; Velazquez E; White H; Howlett J; Swedberg K; Maggioni A; Køber L; Van de Werf F; Califf R; Pfeffer M
    J Am Coll Cardiol; 2006 Feb; 47(4):726-33. PubMed ID: 16487836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role of angiotensin-converting enzyme inhibition in myocardial ischemia and current clinical trials.
    Pepine CJ
    Clin Cardiol; 1997 Nov; 20(11 Suppl 2):II-58-64. PubMed ID: 9422854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [ACE inhibitors and angiotensin II receptor antagonists in acute coronary syndrome].
    Milicić D
    Acta Med Croatica; 2004; 58(2):129-34. PubMed ID: 15208798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [ACE inhibitor after myocardial infarct: are there differences?].
    Jahrmärker H
    Herz; 1995 Aug; 20(4):293-6. PubMed ID: 7557832
    [No Abstract]   [Full Text] [Related]  

  • 14. [The long way of angiotensin-converting enzyme inhibitors in the fight against cardiovascular diseases].
    Ferrari R; Ambrosio G; Chiariello M
    Ital Heart J; 2005 Nov; 6 Suppl 7():3S-4S. PubMed ID: 16485511
    [No Abstract]   [Full Text] [Related]  

  • 15. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACE inhibitors vs. angiotensin II receptor blockers in acute myocardial infarction and heart failure.
    Gold JA; Rahko PS
    WMJ; 2004; 103(1):71-2. PubMed ID: 15101473
    [No Abstract]   [Full Text] [Related]  

  • 17. [Angiotensin I converting enzyme inhibitors in ischemic cardiopathy].
    Ribeiro C
    Rev Port Cardiol; 1991 Apr; 10(4):345-53. PubMed ID: 1888525
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of ACE inhibition on neurohormones.
    Remme WJ
    Eur Heart J; 1998 Sep; 19 Suppl J():J16-23. PubMed ID: 9796836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is a combination of verapamil and an ACE-inhibitor the optimal solution in ischaemic heart failure?
    Jespersen CM
    Cardiologia; 1995 Dec; 40(12 Suppl 1):307-10. PubMed ID: 8903054
    [No Abstract]   [Full Text] [Related]  

  • 20. [Efficacy of angiotensin-converting enzyme inhibitors in secondary prevention].
    Ceconi C; Mastrorilli F; Squasi PA; Gaitani S; Guardigli G; Ferrari R
    Ital Heart J; 2005 Nov; 6 Suppl 7():5S-13S. PubMed ID: 16485512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.